Inside Precision Medicine Marketplace Healthcare Informatics CENTOGENE NEW CentoGenome®

Centogene
CENTOGENE NEW CentoGenome®

Serving as a first-line test, CENTOGENE’s NEW CentoGenome is the most comprehensive commercially available Whole Genome Sequencing (WGS) test on the market for both rare and neurodegenerative disorders – covering almost all disease-causing variants, including most known repeat expansions associated with neurological diseases, in a single assay1. NEW CentoGenome also detects Copy Number Variations (CNVs) associated with Spinal Muscular Atrophy (SMA), as well as disease-causing variants associated with Gaucher Disease (GD) and susceptibility to GBA1-related Parkinson’s Disease (PD), with the highest levels of sensitivity.

1Data on file at CENTOGENE




Centogene

Am Strande 7
18055 Rostock, Germany
+49 (0) 381 80 113 - 416
https://www.centogene.com





Features & Specs

Superior Technology With Unparalleled Clinical Coverage with NEW CentoGenome

  • Advanced Technology for Greater Insights
    Innovative technology with uniform coverage across the entire exome (~20,000 genes), full mitochondrial genome, and known medically-associated genes and variants
  • Superior Performance for Enhanced Disease Coverage
    In leveraging advanced data analysis with CE-IVD bioinformatics and medical expert-based interpretation powered by the CENTOGENE Biodatabank, NEW CentoGenome delivers superior variant detection.
  • Integrated Variant Reclassification and Confirmatory Testing for a Life-Long Commitment
    As a world leader and trusted partner, CENTOGENE provides a free-of-charge and proactive diagnosis confirmation and variant reclassification program.

Features & Specs

Superior Technology With Unparalleled Clinical Coverage with NEW CentoGenome

  • Advanced Technology for Greater Insights
    Innovative technology with uniform coverage across the entire exome (~20,000 genes), full mitochondrial genome, and known medically-associated genes and variants
  • Superior Performance for Enhanced Disease Coverage
    In leveraging advanced data analysis with CE-IVD bioinformatics and medical expert-based interpretation powered by the CENTOGENE Biodatabank, NEW CentoGenome delivers superior variant detection.
  • Integrated Variant Reclassification and Confirmatory Testing for a Life-Long Commitment
    As a world leader and trusted partner, CENTOGENE provides a free-of-charge and proactive diagnosis confirmation and variant reclassification program.
Inside Precision Medicine